Gene Editing

Increasing growth hormone levels can improve liver health in patients with NAFLD

Posted on June 14, 2022 by Editorial Staff

Growth hormone improves liver health in patients with nonalcoholic fatty liver disease (NAFLD) by reducing liver fat and inflammation, according to a new study presented Tuesday, June 14 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.

<img style='max-height: 25px;display:unset;margin:0' class='sfsi_wicon' alt='facebook' src='https://thecrisprsociety.com/wp-content/plugins/ultimate-social-media-icons/images/responsive-icon/facebook.svg'>

Share on Facebook

<img style='max-height: 25px;display:unset;margin:0' class='sfsi_wicon' alt='Twitter' src='https://thecrisprsociety.com/wp-content/plugins/ultimate-social-media-icons/images/responsive-icon/Twitter.svg'>

<img style='max-height: 25px;display:unset;margin:0' class='sfsi_wicon' alt='Follow' src='https://thecrisprsociety.com/wp-content/plugins/ultimate-social-media-icons/images/responsive-icon/Follow.png'>

<img alt='' src='https://secure.gravatar.com/avatar/008c46a8d463cb955213048824ccf788?s=90&d=identicon&r=g' srcset='https://secure.gravatar.com/avatar/008c46a8d463cb955213048824ccf788?s=180&d=identicon&r=g 2x' class='avatar avatar-90 photo' height='90' width='90' />

Editorial Staff